US 10881653
Tricyclic compounds and their use in the treatment of cancer
granted A61KA61K31/407A61K31/439
Quick answer
US patent 10881653 (Tricyclic compounds and their use in the treatment of cancer) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jan 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/407, A61K31/439, A61K31/46, A61P